Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
Gabapentin is widely used in the United States for a number of off-label indications, often as an alternative to opioid therapy. Increasing evidence has emerged suggesting that gabapentin may not be as benign as once thought and may be associated with substance abuse in concert with opioids. With co...
Saved in:
Main Authors: | Alyssa M Peckham (Author), Kirk E Evoy (Author), Leslie Ochs (Author), Jordan R Covvey (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States
by: Kirk E Evoy, et al.
Published: (2020) -
Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
by: Montserrat Viñas-Bastart, et al.
Published: (2022) -
Off-label use of fixed-dose combination of tramadol and dexketoprofen in primary health care. Evidence-based or cause for concern?
by: Montserrat Viñas-Bastart, et al.
Published: (2022) -
Assessment of off-label prescribing: profile, evidence and evolution
by: Encarnación Blanco-Reina, et al.
Published: (2017) -
Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
by: Frontiers Editorial Office
Published: (2023)